Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-13-000293
Filing Date
2013-05-15
Accepted
2013-05-15 16:07:48
Documents
9
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q irsb0331form10q.htm 10-Q 247053
2 EXHIBIT 31.1 irsb0331form10qex311.htm EX-31.1 10170
3 EXHIBIT 32.1 irsb0331form10qex321.htm EX-32.1 4815
  Complete submission text file 0001554795-13-000293.txt   2345611

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE irsb-20130331.xml EX-101.INS 276586
5 XBRL SCHEMA FILE irsb-20130331.xsd EX-101.SCH 32875
6 XBRL CALCULATION FILE irsb-20130331_cal.xml EX-101.CAL 31920
7 XBRL DEFINITION FILE irsb-20130331_def.xml EX-101.DEF 42056
8 XBRL LABEL FILE irsb-20130331_lab.xml EX-101.LAB 198731
9 XBRL PRESENTATION FILE irsb-20130331_pre.xml EX-101.PRE 135417
Mailing Address 5201 GREAT AMERICA PARKWAY SUITE 320 SANTA CLARA CA 95054
Business Address 5201 GREAT AMERICA PARKWAY SUITE 320 SANTA CLARA CA 95054 408 867 2885
IRIS BIOTECHNOLOGIES INC (Filer) CIK: 0001396238 (see all company filings)

EIN.: 770506396 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53245 | Film No.: 13847011
SIC: 3841 Surgical & Medical Instruments & Apparatus